Ticker Scorecard - EQ Basics Company: Equillium, Inc. IPO Date: October 8, 2018 Sector: Healthcare Industry: Biotech Market Cap: $26.75M Activated in VL: True Average Daily Range Avg Daily Range: $0.21 | 4.67% Avg Daily Range (30 D): $0.04 | 4.72% Avg Daily Range (90 D): $0.03 | 4.52% Institutional Daily Volume Avg Daily Volume: .27M Avg Daily Volume (30 D): 1.04M Avg Daily Volume (90 D): .44M Trade Size Avg Trade Size (Sh.): 199 Avg Trade Size (Sh.) (30 D): 480 Avg Trade Size (Sh.) (90 D): 482 Institutional Trades Total Inst.Trades: 27 Avg Inst. Trade: $1.31M Avg Inst. Trade (30 D): $.71M Avg Inst. Trade (90 D): $.71M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.57M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 179.46K     News Sep 22, 2024 @ 4:30 AM Graft versus Host Disease Market to Increase at a ... Source: Delveinsight Sep 16, 2024 @ 1:00 PM Vivtex Enters New Research Agreement w... Source: N/A May 9, 2024 @ 9:35 PM Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue... Source: Zacks Equity Research May 8, 2024 @ 10:25 PM Alector (ALEC) Reports Q1 Loss, Tops Revenue Estim... Source: Zacks Equity Research Apr 1, 2024 @ 1:52 PM 5 Stocks That More Than Doubled in Q1 With More Ga... Source: Sweta Killa Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.13 $ $.01 Diluted EPS $-.13 $ $.01 Revenue $ 45.91M $ 12.16M $ 13.85M Gross Profit $ $ $ Net Income / Loss $ -4.62M $ -.01M $ .47M Operating Income / Loss $ -6.77M $ -.68M $ -.1M Cost of Revenue $ $ $ Net Cash Flow $ -18.97M $ 4.34M $ -12.16M PE Ratio